Verge Genomics

A small plant growing in a crack in the ground with a shadow of a tree behind it

Biotech

Verge drops sole clinical candidate in return to AI roots

The decision comes after VRG50635, the company’s lead asset for ALS, failed a pre-specified efficacy analysis in a phase 1 trial.

Darren Incorvaia Dec 18, 2025 10:04pm

ALS neurons brain synapses

Ferrer offers $122M biobucks for ex-US license to Verge ALS drug

Mar 25, 2024 8:16am

merge MA railway train tracks path together

AstraZeneca converges with Verge's AI tech in $42M R&D pact

Sep 8, 2023 7:00am

parachutes ladders

Roche taps new North American diagnostics chief—Chutes & Ladders

Dec 9, 2022 9:30am

Parachute

Ayala, Advaxis merger means new leadership team—Chutes & Ladders

Oct 21, 2022 9:30am

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am